Abstract:Glycolipid metabolism disorders (GLMDs) have been reported to be involved in dysfunctions of a few key enzymes such as ATP-citrate lyase (ACL) and death-associated protein kinase (DAPK)-related apoptosis inducing protein kinase-2 (DRAK2). Exploring new and effective small molecule ligands for these enzymes, natural products are expected to have the advantage over synthesized compounds. In our preceding work, a number of C50 terpenoids with bioactivities against ACL have been found from Pseudotsuga forrestii (a ‘vulnerable’ Yunnan Douglas fir) by the guidance of an LC-MS/MS-based molecular ion networking strategy. The combination of the rest portions of the EtOAc fraction from this precious plant sample did not predict any C50 compounds, but it was detected to be rich in C40/C30/C20 terpenoids and preliminarily exhibited DRAK2 inhibition. In this follow-up study, ten undescribed terpenoids (1−10) and 25 structurally related known compounds were further isolated and characterized. The new structures and their absolute configurations were determined by spectroscopic methods and/or X-ray diffraction analyses. 7,13-Friedo-lanostanes 1 and 2 feature intriguing skeletons with an unusual α, β-unsaturated spirolactone unit formed between C-13 and C-23 via oxygen-bridge or with an 8(14→13)-abeo moiety. Triterpene-monoterpene hybrid 3 could be regarded as a unique tetraterpene formed by intermolecular [4 + 2] Diels-Alder cycloaddition between a rearranged lanostane (dienophile) and a β-myrcene (diene). Methyl 15-methoxy-8,11,13-abietatrien-18-yl-succinate (9) and 3-oxo-24(E)-lanosta-8,24-dien-26-oic acid (35) were confirmed to have DRAK2 inhibitory effects with IC50 values of 6.6 and 4.1 μM, respectively. A molecular docking study disclosed alternative H-bonds/interacting amino acid residues between compounds 9/35 and the DRAK2 enzyme when comparing with those of the synthesized inhibitors reported in literature. The above findings could support the important role of protecting plant species diversity in support of chemical diversity and potential sources of new therapeutic agents for the treatment of GLMDS.

Structure-diversified terpenoids from Salvia prattii and their protective activity against alcoholic liver diseases

Aromatic Abietane‐Type Diterpenoids from the Roots of Salvia prattii and Their Protective Activity Against alcoholic liver disease

Terpenoids with Anti-Inflammatory Activity from Abies Chensiensis.

11,12-seco-Abietane-type diterpene lactones with potential antiplatelet activity from Salvia prattii

Structure and bioactivity of triterpenoids from the stems of Schisandra sphenanthera

Identification of diterpenoids from Salvia castanea Diels f. tomentosa Stib and their antitumor activities

Polyoxygenated sesquiterpenoids from Salvia castanea and their potential anti-Alzheime's disease bioactivities

Anti-inflammatory oxazole-, nitro- and hexahydropyrrolo[2,1- b ]oxazole-containing abietane diterpenoid alkaloids from Salvia miltiorrhiza

Triterpenes from antler-shaped fruiting body of Ganoderma lucidum and their hepatoprotective activities

Two Undescribed Germacrane‐Type Sesquiterpenoids from Salvia cavaleriei var. simplicifolia Stib. and Their Anti‐Alzheimer's Disease Activity

New Depsides from the Roots of Salvia Miltiorrhiza and Their Radical-Scavenging Capacity and Protective Effects Against H2O2-induced H9c2 Cells.

Purification, Molecular Docking and Cytotoxicity Evaluation of Bioactive Pentacyclic Polyhydroxylated Triterpenoids from Salvia urmiensis

Highly oxygenated germacrane-type sesquiterpenoids from the whole plant of Salvia cavaleriei H.Lév. and their biological activities

Lignans and Diterpenes Isolated from Tirpitzia Ovoidea and Their Biological Activities

Absolute Configuration and Biological Evaluation of Novel Triterpenes as Possible Anti-Inflammatory or Anti-Tumor Agents

Genetics of kidney development.

Alpha-Glucosidase and Alpha-Amylase Inhibitory Activities of Novel Abietane Diterpenes from Salvia africana-lutea

Involvement of G Protein-Coupled Receptor Kinase (GRK) 3 and GRK2 in Down-Regulation of the α2B-Adrenoceptor

Structurally Diverse Terpenoids and Their DRAK2 Inhibitory Activities: A Follow-Up Study on the Vulnerable Conifer Pseudotsuga Forrestii

Regioisomers Salviprolin A and B, Unprecedented Rosmarinic Acid Conjugated Dinorditerpenoids from Salvia przewalskii Maxim

Icetexane diterpenoids as Cav3.2 T-type calcium channel inhibitors from Salvia prattii and analgesic effect of their Semi-synthesized derivatives